Russo Edge Podcast

Russo Edge Podcast

Download on the App Store

Russo Edge Podcast episodes

  • Biotech Horizons: Industry Evolution, Q4 Outlook, and Key Catalysts with Graig Suvannavejh

    Join Graig Suvannavejh, veteran biotech and biopharmaceutical analyst at Mizuho Securities, as he sits down with our host Solomon Wilcots, Sports-Health Alliance Team Leader at Russo Partners.

    In this episode, Graig discusses the evolving biotech landscape, upcoming market catalysts, and the key therapeutic areas poised for growth. We also dive into best practices for companies looking to strengthen relationships with analysts and investors.

    16 min
  • Revolutionizing Medicine with Cell Therapy: A Conversation with Brian Culley, CEO of Lineage Cell Therapeutics

    Can cell therapy provide a real solution for spinal cord injuries, as well as vision and hearing loss? In this episode, Solomon Wilcots speaks with Brian Culley, CEO of Lineage Cell Therapeutics, about how their groundbreaking work is creating new possibilities for patients.

    Brian shares how replacing damaged cells with healthy ones is transforming the recovery process. Discover Lineage Cell Therapeutics’ latest advancements and how they could reshape the future of medicine.

    8 min
  • Orthopedic Innovations: Dr. Scott Sigman’s Approach to Athlete and Patient Care

    Join Dr. Scott Sigman, a renowned orthopedic surgeon with Spire Orthopedic Partners and host of The Ortho Show, as he sits down with our host Solomon Wilcots, Sports-Health Alliance Team Leader at Russo Partners.

    In this insightful episode, Dr. Sigman discusses his work with elite athletes like the LA Lakers and Dodgers, and how those experiences have shaped his approach to patient care. Learn about the latest advancements in knee and shoulder surgeries, the importance of communication, and building strong patient relationships.

    11 min

About Russo Edge Podcast

From the publisher's feed

On the Russo Edge Podcast, we interview compelling leaders, innovators, investors, and decision-makers in life sciences. Our engaging dialogues with those behind health breakthroughs center around the…